About
Basic Data Updated:
4 months agoIn the year 1989, the production of anti leprosy bulk drug clofazimine I.P/B.P was started by Sangrose Laboratories Private Limited. This marked the beginning of the company's journey in the pharmaceutical industry. The initial capacity of one ton/annum was a humble start, but the company's determination and hard work led to its growth and success. Alongside the production of clofazimine, the company also established a soft gelatin encapsulation unit in the same year. As the demand for pharmaceutical products increased, Sangrose Laboratories Private Limited expanded its operations. The company ventured into the production of other dosage forms such as tablets, hard gelatin capsules, creams, ointments, and liquid orals. This move not only diversified the company's product portfolio but al... Read More
Industry
Company Details
- Location
Alappuzha, Kerala, India
- Website1222442
- Telephone1222442
- Email Address1222442
CIN/LLPIN/FCRN | U24231KL1996PTC010099 |
Company No. | 010099 |
Company Classification | Private Limited Indian Non-Government Company |
Incorporation Date | 01 Mar 1996 |
Date of AGM | 30 Sep 2023 |
Date of Balance Sheet | 31 Mar 2023 |
Listing Status | Unlisted |
ROC Code | Roc Ernakulam |
Financials of Sangrose Laboratories Private Limited
Enhance accessibility to Sangrose Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Sangrose Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Sangrose Laboratories Private Limited
Unlock and access historical data on people associated with Sangrose Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (1)
AK
Alexander Kunjummen Managing DirectorAppointment Date: 01-Mar-1996
Status: Current
Board Members(3)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 17 Jan 1994 | ₹1.87 Cr | Open |
Kerala Financial Corporation Creation Date: 03 Sep 2013 | ₹7.68 M | Satisfied |
Kerala Financial Corporation Creation Date: 01 Jul 2003 | ₹7.50 M | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sangrose Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sangrose Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Sangros Drugchem Private Limited
Active 28 years 3 monthsAlexander Kunjummen and Thomas Alexander are mutual person
Recent activity within the organization
Annual General Meeting
Sangrose Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023Balance Sheet
Sangrose Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ernakulam.
31 Mar 2023Charges
A charge registered on 03 Sep 2013 via Charge ID 10446500 with Kerala Financial Corporation was fully satisfied on 26 Oct 2022.
26 Oct 2022Charges
A charge with State Bank Of India of Rs. 187.00 Lakh registered on 17 Jan 1994 with Charge ID 90016114 was modified on 16 Jun 2021.
16 Jun 2021Charges
A charge with Kerala Financial Corporation amounted to Rs. 76.75 Lakh with Charge ID 10446500 was registered on 03 Sep 2013.
03 Sep 2013
Frequently asked questions
What is the Incorporation or founding date of Sangrose Laboratories Private Limited?